Gene Therapy Development 2024

13 - 14 June 2024 | London, UK

Thank you to all attendees, speakers, and sponsors of Gene Therapy Development 2024 for making this event a success.

You may be interested in Cell 2024.

Event Page - Hero Banner 6

Explore Gene Therapy Development 2024: Unlocking Future Insights in Gene Therapy Development Research

The 3rd Annual Gene Therapy Development Congress unites leading experts working in gene therapy development to provide a comprehensive journey through the latest advances and challenges, with the aim of accelerating gene therapy production.

3rd Annual Gene Therapy Development Congress

Gain an end-to-end outlook on the entire journey of gene therapy development, with 5 tracks exploring the discovery, clinical trial, manufacturing, and commercialisation of gene therapies.

Tackle the latest challenges in our interactive sessions featuring panel discussions and roundtables, addressing pressing issues such as vector design, gene engineering, preparing for regulatory changes, and more

Benefit from real-world case studies presented by industry experts, including insights into how to navigate regulatory submission, as well as operationalising clinical trials

Acquire practical solutions to overcome obstacles in the development and production of gene therapies, with opportunities to meet with and hear from vendor companies

Agenda at a Glance

  • Day One | Track 1: Vector Development
  • Day One | Track 2: Gene Therapy Manufacturing & Supply Chain 
  • Day One | Track 3: Pre-clinical and Clinical Therapeutic Development
  • Day Two | Track 1: Gene Therapy Analytics
  • Day Two | Track 2: Emerging Targets and Gene Editing Tools and Strategies

What to Expect


leading pharma, biotech, & academic delegates

hours of presentations, discussions & interactive content
hours of networking breaks, including speed networking & refreshments
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 45 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Gene Therapy Development 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Alba Guijarro Belmar
Head of Vector Development,
Sania Therapeutics
Alberto del Rio Espinola
GentiBio Inc
Amin Hajitou
Imperial College London
Charlotte Smerdon
Senior Director, Clinical Operations,
Purespring Therapeutics
Giandomenico Turchiano
Associate Director,
James Norton
Director analytical development,
Jane Kinghorn
Director Translational Research Office,
University College London
Johnson Varghese
Head of Analytical Development,
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHS Blood and Transplant
Nathalie Cartier-Lacave
Senior Vice President Neurobiology,
Breech Conrad Odu
Process Development Scientist,
Merck Life Sciences
Chrysanthi Sitmalidou
Scientist II,
Orchard Therapeutics
Claudio Mussolino
Group Leader,
Medical Center - University of Freiburg
De Cupere Vinciane
technical lead,
Elina Hessels
Associate Director Analytical Platforms,
Ellina Allais
Regulatory Affairs Senior Director,
Cellectis S.A.
Eugenio Macchiarulo
Director MSAT,
Barinthus Bio
Khalid Saeed
Senior Scientist,
Koval Smith
Snr Manager,
Lily li
lead scientist,
Mana Yen
Gene Therapies - Global Head of Health Systems and Policy at Novartis Gene Therapies.,
Michel Degueldre
Lead GT Biophysical Sciences,
Nina Kotsopoulou
Chief Technology Officer,
Xap Therapeutics
Pamela Whalley
Associate Director, CMC,
Complement Therapeutics
Patricia Lareo
Value Chain Capability Lead Gene Therapy,
Peter Pechan
Head of Vector Biology and Discovery,
Yen Choo
Founder & Chairman; Associate Professor of Stem Cell Science and Regenerative Medicine,
Plasticell; Lee Kong Chian School of Medicine Science
Yu-Tsan (Richard) Liu
Sr. Scientist,
UCB Pharma

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Reshaping Genome Editing: Doudna & Charpentier, the Founders of CRISPR/Cas9 and Their Legacy

In 2020 Jennifer Doudna & Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for discovering the revolutionary gene-editing tool CRISPR/Cas9. This article shines a spotlight on their remarkable achievements and addresses current applications and future opportunities for CRISPR/Cas9.

SGS Biologics Services

SGS Biosafety & Characterisation Services

SGS Cell & Gene Therapies

Is Single-Use Bioprocessing the Way Forward?

Danish company Novo Holdings has acquired a majority stake in the Austrian-based company Single Use Support, marking a critical stride towards the wider adoption of single-use bioprocessing tools.

Implementing Process Analytical Technology into Cell and Gene Therapy Manufacturing

A recent study shows that a novel refractometry-based PAT system monitors metabolic activity during CGT production, revealing insights into optimising bioprocesses.

Plan Your Visit

ILEC Conference Centre
47 Lillie Rd London SW6 1UD United Kingdom

By Underground

Sitting at the edge of zone 1, West Brompton and Earls Court stations are both within walking distance giving easy access to all central districts of London and Heathrow Airport. Transport for London tube map.

By Car

ILEC is a quarter of a mile (400m) from the A4, providing easy access to the M4, M5 and M40.

By Air

Heathrow (LHR): 21 km - Approximately 30 minutes in light traffic. You can also reach the airport directly by London Underground, on the Piccadilly line. Gatwick (LGW): 45 Km - Approximately an hour in light traffic. It is 40 minutes by train from West Brompton station via Clapham Junction. Direct shuttle available with Easy Bus. London City (LCY): 21 km - Approximately 45 minutes in light traffic.


There is a car park adjacent to ILEC with 140 parking bays. The parking is NOT managed by ILEC so spaces cannot be reserved and may become full during busy events. Guests and delegates can benefit from preferential parking rates as follows: Up to 2 hours £7 Up to 4 hours £11 Up to 6 hours £14 Up to 9 hours £16 (£21 for non-residents) Up to 12 hours £20 (£26 for non-residents) Up to 24 hours (overnight) £26

Oxford Global have secured a number of bedrooms at ibis London Earls Court at a reduced rate:


Wednesday 12th June 2024 – £176, breakfast included

Thursday 13th June 2024 – £176, breakfast included


Should you wish to book a room, please click here.


The final cut-off date to book bedrooms is Monday 27th May 2024 – any bookings after this date are subject to availability and rates. Please note, that any cancellations within 14 days prior to arrival are subject to cancellation charges.


Additionally, we kindly remind all attendees to only book their accommodation if they are registered for the event. This ensures that accommodations are available for those who have officially secured their attendance.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Gene Therapy Development 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch